Physician profile
Robby A Amiot
NPI 1568452175
$4,322.48
in general payments reported to CMS, 2019-2025
14 companies · $219 in 2025
The $219 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,550 · 2020: $98.13 · 2021: $261 · 2022: $759 · 2023: $1,318 · 2024: $117 · 2025: $219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,000 · Food and Beverage: $655.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,000.00 |
| Food and Beverage | $654.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $1,489.60 | 2019 | |
| Linvatec Corporation | $1,200.15 | 2022-2023 | Colink Plating System, Fracture and Correction Colag 2 |
| In2bones USA, LLC | $521.20 | 2022 | |
| Stryker Corporation | $454.55 | 2021-2024 | Infinity, Prostep Mica |
| Medshape, INC. | $149.37 | 2025 | Dynanail, Dynanail Helix, Washer, 15 Mm |
| Zimmer Biomet Holdings, INC. | $114.85 | 2021-2022 | |
| Depuy Synthes Products, INC. | $75.42 | 2019-2020 | |
| Polynovo North America LLC | $71.00 | 2020 | |
| Smith+Nephew, INC. | $64.17 | 2021-2022 | |
| Orthofix Medical, INC. | $62.59 | 2021-2025 | Physio-Stim |
| Treace Medical Concepts, INC. | $60.22 | 2025 | |
| Organogenesis INC. | $47.53 | 2023 | Puraply |
| Merck Sharp & Dohme LLC | $11.83 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$346,300.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robby Amiot listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.